TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1532760

Group type: EXPERIMENTAL
Intervention: Manipulative therapy
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 256

Group type: COMPARATOR
Intervention: General practitioner treatment
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 256
Study: 3986077

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 9
Study: 29730215

Group type: EXPERIMENTAL
Intervention: Procedure-specific checklist scored in a binary fashion for evaluation of surgical skill
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intra-operative error rate scores
Number of subjects: 44

Group type: COMPARATOR
Intervention: Assessment by 5 teams of faculty assessors
Number of subjects: 44
Study: 26917497

Group type: EXPERIMENTAL
Intervention: LUCAS‐2 device
Number of subjects: 0
Study: 24508922

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 25

Group type: COMPARATOR
Intervention: De-training
Number of subjects: 25
Study: 22219405

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS) as an adjuvant for air leak control (91 patients)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no treatment, 94 patients)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 185
Study: 20591399

Group type: EXPERIMENTAL
Intervention: ranibizumab (0.5 mg/0.05 mL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: sham
Number of subjects: 32
Study: 18978400

Group type: EXPERIMENTAL
Intervention: Electromagnetic stimulation
Number of subjects: 106
Study: 16504620

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration with the 6F Export Aspiration Catheter (Medtronic Corporation)
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Balloon angioplasty before stent implantation
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Conventional primary PCI (balloon angioplasty)
Number of subjects: 1080
Study: 12665327

Group type: EXPERIMENTAL
Intervention: Mammography screening in the first round
Number of subjects: 0

Group type: COMPARATOR
Intervention: Younger age group (reference)
Number of subjects: 0
Study: 11898244

Group type: EXPERIMENTAL
Intervention: Voice-activated method
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Pillbox method
Number of subjects: 61

Group type: COMPARATOR
Intervention: Self-administration of medications (control)
Number of subjects: 61
Study: 8814094

Group type: EXPERIMENTAL
Intervention: 3 years treatment
Number of subjects: 207

Group type: COMPARATOR
Intervention: 1 year treatment
Number of subjects: 207
Study: 1375802

Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: haloperidol
Number of subjects: 42

Group type: COMPARATOR
Intervention: medical controls
Number of subjects: 42
Study: 6703855

Group type: EXPERIMENTAL
Intervention: Amitriptyline (N = 6)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Desipramine (N = 7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Amitriptyline (N = 5) after abrupt cessation of therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Desipramine after abrupt cessation of therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 21
Study: 31273750

Group type: EXPERIMENTAL
Intervention: Experimental agent with adaptive randomization and dose-schedule regimes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Likelihood-based approach to handle unobserved toxicity and efficacy outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation study to evaluate design performance
Number of subjects: 0
Study: 27440189

Group type: EXPERIMENTAL
Intervention: Web-based Acceptance and Commitment Therapy (ACT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 79
Study: 25433006

Group type: EXPERIMENTAL
Intervention: Temocillin administered three times daily (6 g daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Temocillin administered by continuous infusion (6 g daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Temocillin administered by continuous infusion (750 mg daily) in patients undergoing CVVH
Number of subjects: 32
Study: 24906857

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both IVTA and IVB
Number of subjects: 51
Study: 22391143

Group type: EXPERIMENTAL
Intervention: Small item size cookies
Number of subjects: 77

Group type: COMPARATOR
Intervention: Large item size cookies
Number of subjects: 77
Study: 19296044

Group type: EXPERIMENTAL
Intervention: MBP group (40 mg MBP for 8 months)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Whole milk group (8 months)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: MBP group (8 months)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Whole milk group (6 months)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Whole milk group and MBP group combined
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Whole milk group and MBP group
Number of subjects: 84
Study: 17690800

Group type: EXPERIMENTAL
Intervention: Depressive symptoms (measured by CES-D)
Number of subjects: 341
Study: 15534479

Group type: EXPERIMENTAL
Intervention: Contact-topical anesthesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Peribulbar anesthesia
Number of subjects: 80
Study: 11575527

Group type: EXPERIMENTAL
Intervention: Painful electrical stimulation (study P)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No pain (study C)
Number of subjects: 10
Study: 9645636

Group type: EXPERIMENTAL
Intervention: Nafcillin sodium in buffered lidocaine
Number of subjects: 790

Group type: COMPARATOR
Intervention: Placebo (buffered lidocaine hydrochloride)
Number of subjects: 790
Study: 8145904

Group type: EXPERIMENTAL
Intervention: Placebo infusion (saline placebo)
Number of subjects: 68
Study: 3066888

Group type: EXPERIMENTAL
Intervention: Flap with osseous resection surgery (FO)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Modified Widman surgery (MW)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Root planing (RP)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Coronal scaling (CS)
Number of subjects: 82
Study: 30106252

Group type: EXPERIMENTAL
Intervention: Task-switching performance in healthy individuals with a familial history of psychotic disorder
Number of subjects: 536

Group type: COMPARATOR
Intervention: Task-switching performance in healthy individuals without a psychiatrically ill relative
Number of subjects: 536

Group type: COMPARATOR
Intervention: Task-switching performance in individuals with a relative with a mood disorder
Number of subjects: 536

Group type: COMPARATOR
Intervention: Task-switching performance in individuals with a personal history of depression or anxiety
Number of subjects: 536

Group type: COMPARATOR
Intervention: Other cognitive control domains (working memory or risk taking)
Number of subjects: 536
Study: 27799355

Group type: EXPERIMENTAL
Intervention: Messages about harms and addictiveness of waterpipe tobacco smoking (WTS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no messages)
Number of subjects: 0
Study: 26939320

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion (specific acupoints selected based on syndrome differentiation)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Spleen-meridian acupuncture-moxibustion
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (conventional western medicine)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Spleen-meridian group compared to control group
Number of subjects: 180
Study: 22998456

Group type: COMPARATOR
Intervention: Chlorhexidine 0.2% mouthwash
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 1% gel
Number of subjects: 30
Study: 20926135

Group type: EXPERIMENTAL
Intervention: Triamcinolone treatment for CRVO
Number of subjects: 605

Group type: COMPARATOR
Intervention: Standard Care for BRVO
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 605
Study: 19735519

Group type: EXPERIMENTAL
Intervention: Juvéderm injectable gel with lidocaine (JUV + L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Juvéderm injectable gel without lidocaine (JUV)
Number of subjects: 0
Study: 16859530

Group type: EXPERIMENTAL
Intervention: Molecular adsorbent recirculating system (MARS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Prometheus device
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 18
Study: 14642152

Group type: EXPERIMENTAL
Intervention: Group A (CSEA + PCEA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group B (PCIA with tramadol)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 80
Study: 11029829

Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing elastomerics (Fluor‐I‐Ties and Fluor‐I‐Chain)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non fluoride‐releasing elastomerics
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing elastomerics
Number of subjects: 49
Study: 9323649

Group type: EXPERIMENTAL
Intervention: Trunk strength measured during maximum isometric and isokinetic exertions
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Three-dimensional surfaces of trunk strength
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dynamic utilization ratio for trunk muscles
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Strength regressions developed in this study
Number of subjects: 20
Study: 8173183

Group type: EXPERIMENTAL
Intervention: Responders to therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-responders to therapy
Number of subjects: 0
Study: 2944380

Group type: EXPERIMENTAL
Intervention: enprostil (35 micrograms twice daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: ranitidine (150 mg twice daily)
Number of subjects: 21
Study: 30685500

Group type: COMPARATOR
Intervention: Uva-ursi extract
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Ibuprofen advice
Number of subjects: 382
Study: 28234983

Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: HUI3
Number of subjects: 199
Study: 26669226

Group type: EXPERIMENTAL
Intervention: Heavy drinkers (HDs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Light drinkers (LDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Han drinkers (HDs and LDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both HDs and LDs
Number of subjects: 0
Study: 24224242

Group type: EXPERIMENTAL
Intervention: MAP + irradiation (1-4% O2)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Irradiation alone (50 Gy)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: MAP alone (O2 concentrations between 1 and 15%)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: No MAP and no irradiation
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Ziploc storage bags (1-4% O2)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Xtend PP61 bags (3-8% O2)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Xtend PP53 bags (11-15% O2)
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Irradiation at 150 Gy
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Irradiation at 100 Gy
Number of subjects: 9000
Study: 20809991

Group type: EXPERIMENTAL
Intervention: COMET + regular therapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Regular therapy only
Number of subjects: 91
Study: 18295622

Group type: EXPERIMENTAL
Intervention: Functional task practice combined with ankle joint mobilizations
Number of subjects: 16

Group type: COMPARATOR
Intervention: Functional task practice only
Number of subjects: 16
Study: 17154748

Group type: EXPERIMENTAL
Intervention: Major Depressive Disorder (MDD)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Bipolar Affective Disorder (BPAD)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Both MDD and BPAD
Number of subjects: 190
Study: 12540118

Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with SuperSnap (SS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with SuperSnap (SS)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with CompoSite Polishers (CS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with CompoSite Polishers (CS)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with Robot Carbides (RC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with Robot Carbides (RC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Immediate finishing/polishing after light‐polymerization with Photac‐Fil Quick (PF)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Delayed finishing/polishing for one week with Photac‐Fil Quick (PF)
Number of subjects: 64
Study: 11200744

Group type: EXPERIMENTAL
Intervention: Alcohol abusers (group I)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Opiate abusers (group II)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Alcohol abusers (group I) after 9 days of abstinence
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Opiate abusers (group II) after 9 days of abstinence
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Both groups of dependent patients
Number of subjects: 220

Group type: COMPARATOR
Intervention: Healthy persons (control group)
Number of subjects: 220
Study: 8781922

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (25 Gy in five fractions in one week) followed by operation
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1168
Study: 1417537

Group type: EXPERIMENTAL
Intervention: ABO-incompatible group
Number of subjects: 456

Group type: COMPARATOR
Intervention: ABO-compatible group
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Positive crossmatch group
Number of subjects: 456

Group type: COMPARATOR
Intervention: Negative crossmatch group
Number of subjects: 456
Study: 6716644

Group type: EXPERIMENTAL
Intervention: Epidural morphine (3 mg in 1.7 ml physiologic saline solution) administered through the epidural catheter.
Number of subjects: 80
Study: 31721979

Group type: EXPERIMENTAL
Intervention: Liraglutide (up to 1.8 mg per day)
Number of subjects: 9340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study: 29787953

Group type: EXPERIMENTAL
Intervention: Vignette conditions describing psychiatric disorders (schizophrenia and major depressive disorder)
Number of subjects: 994
Study: 27348249

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 2933

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 2933
Study: 24824118

Group type: EXPERIMENTAL
Intervention: LDT monotherapy (600 mg orally, once daily)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDT + ADV combination therapy (LDT 600 mg plus ADV 10 mg orally, once daily)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDT monotherapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LDT + ADV combination therapy
Number of subjects: 140
Study: 22895856

Group type: EXPERIMENTAL
Intervention: Walnuts (75 g/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (usual diet avoiding tree nuts)
Number of subjects: 117
Study: 20188583

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 17392302

Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study: 15926717

Group type: EXPERIMENTAL
Intervention: Paradoxical temporal lobe epilepsy (PTLE) group
Number of subjects: 12

Group type: COMPARATOR
Intervention: Medial temporal sclerosis (MTS) group
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PTLE group
Number of subjects: 12

Group type: COMPARATOR
Intervention: MTS group
Number of subjects: 12
Study: 12198063

Group type: EXPERIMENTAL
Intervention: naproxen (500 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 80
Study: 11500654

Group type: EXPERIMENTAL
Intervention: Sagittal split ramus osteotomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total mandibular subapical alveolar osteotomy
Number of subjects: 40
Study: 9699932

Group type: EXPERIMENTAL
Intervention: 10 MU of reteplase (Group A)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 15 MU of reteplase (Group B)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Bleeding complications
Number of subjects: 142

Group type: COMPARATOR
Intervention: Coronary patency
Number of subjects: 142
Study: 7877158

Group type: EXPERIMENTAL
Intervention: Standardized reactivity assessments with randomized order of resting and reactivity measurements
Number of subjects: 451

Group type: COMPARATOR
Intervention: Standardized reactivity assessments
Number of subjects: 451
Study: 3266005

Group type: EXPERIMENTAL
Intervention: HbOC (Haemophilus influenzae type b mutant-diphtheria toxic conjugate vaccine)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: HbOC (after second dose at 4 months)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: HbOC (after third dose at 6 months)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined passive/active immunization (HbOC and bacterial polysaccharide immunoglobulin) at 2 months
Number of subjects: 51
Study: 30213449

Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg oral per day) plus androgen deprivation therapy
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo plus androgen deprivation therapy
Number of subjects: 1207
Study: 28818054

Group type: EXPERIMENTAL
Intervention: Adductor pollicis muscle acceleromyography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Trapezius muscle acceleromyography
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg/kg IV
Number of subjects: 60
Study: 26202168

Group type: EXPERIMENTAL
Intervention: Tomato soup (2-2¾ cups prepared/d)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tomato sauce (142-198 g/d or 5-7 ounces/d)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Vegetable juice (325-488 ml/d or 11-16.5 fluid ounces/d)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lycopene-restricted control group (< 5 mg lycopene/d)
Number of subjects: 33
Study: 24286114

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB) 4.5 g/night (administered in 2 equally divided doses), with possible increases to 9 g/night or reductions to 4.5 g/night.
Number of subjects: 560
Study: 21384334

Group type: EXPERIMENTAL
Intervention: Two doses of adjuvanted influenza A/09/H1N1 vaccine in patients with inflammatory rheumatic diseases
Number of subjects: 173

Group type: COMPARATOR
Intervention: One dose of adjuvanted influenza A/09/H1N1 vaccine in healthy controls
Number of subjects: 173

Group type: COMPARATOR
Intervention: Baseline antibody levels in patients and controls
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: First dose response in both groups
Number of subjects: 173
Study: 17957120

Group type: EXPERIMENTAL
Intervention: Lyophilised form of B. animalis DN‐173 010
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fermented product of B. animalis DN‐173 010
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 12
Study: 16616012

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (585 mg of docosahexaenoic acid and 225 mg of eicosapentaenoic acid)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 14651731

Group type: EXPERIMENTAL
Intervention: Belladonna 30C
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 10836774

Group type: EXPERIMENTAL
Intervention: Debriefing interview group
Number of subjects: 132

Group type: COMPARATOR
Intervention: Observation-only group
Number of subjects: 132
Study: 8839521

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 10 to 15 micrograms/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramuscular meperidine, promethazine, and chlorpromazine (MPC) 2 mg/kg meperidine, 0.5 mg/kg promethazine, 0.5 mg/kg chlorpromazine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: OTFC
Number of subjects: 40

Group type: COMPARATOR
Intervention: MPC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 1610630

Group type: EXPERIMENTAL
Intervention: 20 ml kg‐1 of 4% glucose and 0.18% saline (group II)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No preoperative fluid (group I)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (I and II)
Number of subjects: 30
Study: 30735532

Group type: EXPERIMENTAL
Intervention: High social deprivation
Number of subjects: 6768

Group type: COMPARATOR
Intervention: Low social deprivation
Number of subjects: 6768
Study: 29641584

Group type: EXPERIMENTAL
Intervention: Revealed identity of the receiver
Number of subjects: 632

Group type: COMPARATOR
Intervention: Anonymous ultimatum game
Number of subjects: 632
Study: 26997191

Group type: EXPERIMENTAL
Intervention: Parenting program
Number of subjects: 816
Study: 25764255

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation consisting of 16 individual one-hour sessions of therapist-guided computer exercises.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham intervention performed by the control group (CG).
Number of subjects: 92

Group type: COMPARATOR
Intervention: Cognitive rehabilitation (SG) vs. Sham intervention (CG).
Number of subjects: 92
Study: 23088514

Group type: EXPERIMENTAL
Intervention: 30 g/day of yellow passion fruit peel flour for two months
Number of subjects: 43
Study: 21243915

Group type: EXPERIMENTAL
Intervention: 1xRDA MMS preparation (14 vitamins and minerals)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: 2xRDA MMS preparation
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Pooled effect of MMS preparations
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: 1xRDA MMS preparation
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Iron-folic acid supplementation
Number of subjects: 2100